Wednesday, July 8, 2026

pharma · SH2B1 Deficiency Obesity · Prader-Willi Syndrome · SLNO

SOLENO THERAPEUTICS

News and analysis for SOLENO THERAPEUTICS on NovaPharmaNews — regulatory, clinical, and market coverage.

Redwood City, USA HQ
199 Employees
Public company Type
SLNO · NYSE Ticker
Company details
Status
Public
HQ
Redwood City, USA
Employees
199
Programs
2
Drugs
4
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning SOLENO THERAPEUTICS — regulatory, clinical, and market coverage.

News and analysis for SOLENO THERAPEUTICS on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning SOLENO THERAPEUTICS yet.

Back to company overview →